We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PACB market cap is 468.92M. The company's latest EPS is USD -1.1447 and P/E is -1.48.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 28.03M | 27.35M | 38.9M | 47.57M | 55.69M |
| Operating Income | -74.62M | -84.86M | -91.25M | -73.18M | -82.49M |
| Net Income | -76.97M | -84.38M | -88.02M | -69.83M | -66.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 90.89M | 78.89M | 130.51M | 128.3M | 200.52M |
| Operating Income | -100.55M | -104.39M | -210.44M | -307.2M | -334.47M |
| Net Income | -84.13M | 29.4M | -181.22M | -314.25M | -306.74M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.82B | 1.77B | 1.9B | 1.85B | 1.9B |
| Total Liabilities | 1.19B | 1.2B | 1.2B | 1.21B | 1.13B |
| Total Equity | 626.59M | 562.9M | 692.12M | 642M | 763.74M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 147.99M | 413.98M | 2.01B | 1.77B | 1.75B |
| Total Liabilities | 93.07M | 78.49M | 1.22B | 1.2B | 1.04B |
| Total Equity | 54.92M | 335.49M | 790.99M | 562.9M | 701.3M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -202.65M | -263.21M | -94.69M | -136.43M | -201.61M |
| Investing | 35.68M | 116.08M | -72.55M | -171.14M | 71.18M |
| Financing | 8.8M | 9.62M | 195.99M | 191.27M | 190.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -78.31M | 19.5M | -111.18M | -263.21M | -259.17M |
| Investing | 62.05M | -219.32M | -678.53M | 116.08M | 4.6M |
| Financing | 26.55M | 251.84M | 1.17B | 9.62M | 108.89M |
| Market Cap | 468.92M |
| Price to Earnings Ratio | -1.48 |
| Price to Sales Ratio | 2.26 |
| Price to Cash Ratio | 2.52 |
| Price to Book Ratio | 0.65 |
| Dividend Yield | - |
| Shares Outstanding | 267.95M |
| Average Volume (1 week) | 9.85M |
| Average Volume (1 Month) | 12.9M |
| 52 Week Change | -83.46% |
| 52 Week High | 14.55 |
| 52 Week Low | 1.25 |
| Spread (Intraday) | 0.03 (1.71%) |
| Company Name | Pacific Biosciences of California Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.pacb.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
